XML 28 R18.htm IDEA: XBRL DOCUMENT v3.25.3
Leases
9 Months Ended
Sep. 30, 2025
Leases [Abstract]  
Leases

Note 7. Leases

In 2021, the Company entered into a noncancelable operating lease for approximately 100,000 square feet in Fremont, California used for laboratory operations and its corporate headquarters. The lease term is 13.5 years and commenced in October 2022. The Company gained early access to the premises for the purpose of constructing and installing tenant improvements, for which the landlord contributed $15.1 million. Such contributions were accounted for as lease incentives and are recognized as reductions to lease expense over the lease term. The lease expires at the end of March 2036 and includes two options to extend the term for a period of five-years per option at market rates. The Company determined the extension options are not reasonably certain to be exercised. The lease includes escalating rent payments.

The Company has a noncancelable operating lease expiring in November 2027 for 31,280 square feet in Menlo Park, California previously used for laboratory operations and its former corporate headquarters. The lease includes escalating rent payments. The Company moved all laboratory operations to the Fremont facility during the third quarter of 2023, resulting in a lease impairment charge at that time. The Company is actively marketing the vacated Menlo Park space for sublease.

The Company has noncancelable operating leases for data center space expiring between 2025 and 2026. The leases include renewal options that the Company determined are not reasonably certain to be exercised. Separately, the Company also has various other short-term leases.

As of September 30, 2025, operating leases had a weighted-average remaining lease term of 9.5 years and a weighted-average discount rate of 10.6%. Discount rates are based on estimates of the Company's incremental borrowing rate, as the discount rates implicit in the leases cannot be readily determined. Future lease payments under operating leases as of September 30, 2025 were as follows (in thousands):

 

 

Amount

 

2025 (remaining three months)

 

$

1,832

 

2026

 

 

7,230

 

2027

 

 

7,189

 

2028

 

 

5,215

 

2029

 

 

5,371

 

2030 and thereafter

 

 

37,426

 

Total future minimum lease payments

 

 

64,263

 

Less: imputed interest

 

 

(24,705

)

Present value of future minimum lease payments

 

 

39,558

 

Less: current portion of operating lease liability (included in accrued and other current liabilities)

 

 

(6,900

)

Long-term operating lease liabilities

 

$

32,658

 

Cash paid for operating lease liabilities, included in cash flows from operating activities in the consolidated statements of cash flows, for the nine months ended September 30, 2025 and 2024, was $6.2 million and $6.1 million, respectively.

Components of lease costs were as follows (in thousands):

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Lease cost

 

 

 

 

 

 

 

 

 

 

 

 

Operating lease cost

 

$

1,460

 

 

$

1,503

 

 

$

4,409

 

 

$

4,535

 

Short-term lease cost

 

 

1

 

 

 

1

 

 

 

3

 

 

 

197

 

Variable lease cost

 

 

537

 

 

 

513

 

 

 

1,444

 

 

 

1,539

 

Total lease cost

 

$

1,998

 

 

$

2,017

 

 

$

5,856

 

 

$

6,271

 

 

In September 2025, the Company entered into an agreement to lease lab equipment for 36 months with 33 monthly payments of $71,479, commencing in January 2026. The Company classified this lease as a finance lease as the agreement contains an early buyout option which the Company is reasonably certain to exercise. Pursuant to the early buyout option, the Company can purchase the equipment and simultaneously terminate the agreement by paying the purchase price of $2.1 million in January 2026. The purchase price was recognized as part of right-of-use ("ROU") finance lease assets and finance lease liabilities. As of September 30, 2025, finance lease ROU assets and ROU liabilities were $3.3 million and $3.2 million, respectively. As of December 31, 2024, the Company had no finance leases. Finance lease ROU assets are classified as long-term assets and are reported within the other long-term assets line in the consolidated balance sheets. Finance lease ROU liabilities with payments due within one year are classified as short-term liabilities and reported within the accrued and other current liabilities line in the consolidated balance sheets. Finance lease ROU liabilities with payments due beyond one year are classified as long-term liabilities and reported with the other long-term liabilities line in the consolidated balance sheets.